Northern Trust Corp Decibel Therapeutics, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.08 - $4.79 $4,259 - $9,809	2,048 Added 12.02%	19,091 $57,000
Q4 2022 Feb 13, 2023	SELL	$1.86 - $3.54 $1,860 - $3,540	-1,000 Reduced 5.54%	17,043 $34,000
Q3 2022 Nov 14, 2022	BUY	$3.82 - $5.61 $14,531 - $21,340	3,804 Added 26.72%	18,043 $62,000
Q4 2021 Feb 08, 2022	SELL	$4.57 - $8.58 $4,570 - $8,580	-1,000 Reduced 6.56%	14,239 $67,000
Q2 2021 Aug 13, 2021	SELL	$6.39 - $11.51 $397,157 - $715,381	-62,153 Reduced 80.31%	15,239 $131,000
Q1 2021 May 12, 2021	BUY	$10.56 - $19.9 $817,259 - $1.54 Million	77,392 New	77,392 $879,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.